T1	Participants 90 138	Japanese patients with type 2 diabetes mellitus.
T2	Participants 489 516	Japanese patients with T2DM
T3	Participants 802 868	36 T2DM patients (18 patients each in 2.5 mg and 10 mg dose group)
